Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 3/2014

01-03-2014 | Cardiac Nuclear Imaging (A Cuocolo Section Editor)

Nuclear Cardiology in Heart Failure

Authors: Selene Capitanio, Cecilia Marini, Matteo Bauckneht, Gianmario Sambuceti

Published in: Current Cardiovascular Imaging Reports | Issue 3/2014

Login to get access

Abstract

Despite recent advances in drug and non-pharmacological treatments, heart failure represents a serious public health problem that is steadily increasing in developed countries. A deeper comprehension of mechanisms underlying this condition still remains the only way to decrease morbidity and mortality in these patients. To this purpose, integrated information on heart failure etiology and pathophysiology is needed for an accurate prediction of patient outcome. Among the currently available non-invasive imaging techniques, nuclear medicine has a peculiar role due to its capability to simultaneously evaluate different aspects of disease and to provide insights into the molecular and cellular mechanisms involved in progression of left ventricular dysfunction. This review aims to synthetically describe possibilities and problems in the radionuclide evaluation of myocardial function, perfusion, innervation and molecular pathways underlying heart failure progression and its complications.
Literature
1.
2.
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123:18–209.CrossRef
3.
Maddox DE, Wynne J, Uren R, et al. Regional ejection fraction: a quantative radionuclide index of regional left ventricular performance. Circulation. 1979;59:1001–9.PubMedCrossRef
4.
Hesse B, Lindhardt TB, Acampa W, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008;35:851–85.PubMedCrossRef
5.
Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016.PubMedCrossRef
6.
Neglia D, Parodi O, Marzullo P, Sambuceti G, et al. Behavior of right and left ventricles during episodes of variant angina in relation to the site of coronary vasospasm. Circulation. 1990;81:567–77.PubMedCrossRef
7.•
Mitra D, Basu S. Equilibrium radionuclide angiocardiography: its usefulness in current practice and potential future applications. World J Radiol. 2012;28(4):421–30. A current review and analysis of an old technique with still a large clinical potential..CrossRef
8.
Abidov A, Hachamovitch R, Berman DS. Modern nuclear cardiac imaging in diagnosis and clinical management of patients with left ventricular dysfunction. Minerva Cardioangiol. 2004;52:505–19.PubMed
9.
Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831–7.PubMed
10.
Kasama S, Toyama T, Kumakura H, et al. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy. J Nucl Med. 2004;45:1878–84.PubMed
11.
Gheorghiade M, Sopko G, De Luca L, et al. Navigating the croassroads of coronary artery disease and heart failure. Circulation. 2006;114:1012–3.CrossRef
12.
Smith Jr SC, Blair SN. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577–9.PubMedCrossRef
13.
Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342:1077–84.PubMedCrossRef
14.
15.
Udelson JE, Shafer CD, Carrio I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol. 2002;9:40–52.CrossRef
16.
Nitszche EU, Choi Y, Czernin J, et al. Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. Circulation. 1996;93:2000–6.CrossRef
17.
El FG, Kardan A, Sitek A, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009;50:1062–71.CrossRef
18.
Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995;92:796–804.PubMedCrossRef
19.
Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186–93.PubMedCrossRef
20.
Schinkel AF, Bax JJ, Poldermans D, et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375–410.PubMedCrossRef
21.
Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884–8.PubMedCrossRef
22.
Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103–14.PubMedCrossRef
23.
Pagano D, Lewis ME, Townend JN, et al. Coronary revascularization for postischaemic heart failure: how myocardial viability affects survival. Heart. 1999;82:684–8.PubMed
24.
Sambuceti G, Giorgetti A, Corsiglia L, et al. Perfusion-contraction mismatch during inotropic stimulation in hibernating myocardium. J Nucl Med. 1998;39:396–402.PubMed
25.
26.
Ghostine S, Caussin C, Habis M, et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J. 2008;29:2133–40.PubMedCrossRef
27.•
Ko BS, Cameron JD, Meredith IT, et al. Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. Eur Heart J. 2012;33:67–77. This work documented the additional value of computed tomography myocardial perfusion imaging used with computed tomography coronary angiography to detect ischemia..PubMedCrossRef
28.•
Bamberg F, Becker A, Schwarz F, et al. Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging. Radiology. 2011;260:689–98. This study conducted on 36 patients, showed the diagnostic accuracy of CT in the detection of coronary artery stenosis in association with a hemodinamically significant reduction of myocardial blood flow..PubMedCrossRef
29.•
Hulten EA, Bittencourt MS, Ghoshhajra B, et al. Stress CT perfusion: coupling coronary anatomy with physiology. J Nucl Cardiol. 2012;19:588–600. In this review the authors underlined the strengths and the limitations of CT in the evaluation of coronary anatomy and myocardial perfusion..PubMedCrossRef
30.
Bauer RW, Kerl JM, Fischer N, et al. Dual-energy CT for the assessment of chronic myocardial infarction in patients with chronic coronary artery disease: comparison with 3-T MRI. AJR Am J Roentgenol. 2010;196:W550–7.
31.
Sambuceti G, Marini C, Morbelli S, et al. Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events? J Nucl Cardiol. 2009;16:447–55.PubMedCrossRef
32.
Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–8.PubMedCrossRef
33.
Cohn J, Levine T, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med. 1984;311:819–82.PubMedCrossRef
34.
Engelhardt S, Hein L, Wiesmann F, et al. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A. 1999;96:7059–64.PubMedCentralPubMedCrossRef
35.
Freeman K, Lerman I, Kranias EG, et al. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest. 2001;107:967–74.PubMedCentralPubMedCrossRef
36.
Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667–76.PubMedCrossRef
37.
Hattori N, Schwaiger M. Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med. 2000;27:1–6.PubMedCrossRef
38.
Carrió I, Cowie MR, Yamazaki J, et al. Cardiac sympathetic imaging with MIBG in heart failure. JACC Cardiovasc Imaging. 2010;3:92–100.PubMedCrossRef
39.
Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 meta- iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef
40.
Nishisato K, Hashimoto A, Nakata T, et al. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs. J Nucl Med. 2010;51:1241–9.PubMedCrossRef
41.
Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 Metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol. 2009;53:426–35.PubMedCrossRef
42.
Boogers MJ, Borleffs CJ, Henneman MM, et al. Cardiac sympathetic denervation assessed with 123-Iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77.PubMedCrossRef
43.
Marini C, Giorgetti A, Gimelli A, et al. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy. Eur J Nucl Med Mol Imaging. 2005;32:682–8.PubMedCrossRef
44.
45.
Su H, Spinale FG, Dobrucki LW, et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112:3157–67.PubMedCrossRef
46.
Boersma HH, Kietselaer BLJH, Stolk LML, et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med. 2005;46:2035–50.PubMed
47.
Lefebvre F, Prefontaine A, Calderone A, et al. Modification of the pulmonary renin-angiotensin system and lung structural remodelling in congestive heart failure. Clin Sci (Lond). 2006;111:217–24.CrossRef
48.
Asano Y, Ihn H, Yamane K, et al. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol. 2005;175:7708–18.PubMed
49.
Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev. 2007;87:1285–342.PubMedCrossRef
50.
Wilson EM, Moainie SL, Baskin JM, et al. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling. Circulation. 2003;107:2857–63.PubMedCrossRef
51.
Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.PubMedCrossRef
52.
Poulsen SH, Host NB, Jensen SE, et al. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation. 2000;101:1527–32.PubMedCrossRef
53.
Van den Borne SWM, Isobe S, Zandbergen HR, et al. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. J Am Coll Cardiol Img. 2009;2:187–98.CrossRef
54.
Verjans JW, Lovhaug D, Narula N, et al. Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging. 2008;1:354–62.PubMedCentralPubMedCrossRef
55.
Mann DL. Molecular Imaging and the failing heart. J Am Coll Cardiol Img. 2009;2:199–201.CrossRef
Metadata
Title
Nuclear Cardiology in Heart Failure
Authors
Selene Capitanio
Cecilia Marini
Matteo Bauckneht
Gianmario Sambuceti
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Cardiovascular Imaging Reports / Issue 3/2014
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-013-9256-7

Other articles of this Issue 3/2014

Current Cardiovascular Imaging Reports 3/2014 Go to the issue

Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)

Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues

Cardiac Nuclear Imaging (A Cuocolo, Section Editor)

Myocardial Perfusion Imaging for Risk Stratification in Asymptomatic Individuals Without Known Cardiovascular Disease

Cardiac Nuclear Imaging (A Cuocolo Section Editor)

Cardiac Radionuclide Imaging After Coronary Artery Revascularization

Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)

Myocardial Tissue Characterization: Histological and Pathophysiological Correlation